Non-invasive treatment for lung tumors using thermal ablation
Percutaneous Thermal Ablation in Treatment of Lung Cancer
This study is testing a new way to treat lung tumors using heat without surgery for patients who can't have surgery due to other health issues.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Sex | All |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Asyut) |
| Trial ID | NCT06891183 on ClinicalTrials.gov |
What this trial studies
This clinical trial focuses on using percutaneous thermal ablation techniques, specifically radio frequency ablation (RFA) and microwave ablation (MWA), to treat lung tumors in patients who are not eligible for surgery due to comorbidities. The study aims to destroy tumor tissue with minimal invasiveness, guided by computed tomography for precision. By heating the targeted tissue to induce necrosis, the trial seeks to provide a safer alternative for patients with smaller lung cancers or metastasis. The approach is designed to avoid the risks associated with traditional surgical procedures.
Who should consider this trial
Good fit: Ideal candidates include patients with lung cancer smaller than 5 cm and those with multiple comorbidities unfit for surgery.
Not a fit: Patients with lung cancer larger than 5 cm or those with stage II or more lung cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could offer a safer, effective option for patients with lung cancer who cannot undergo surgery.
How similar studies have performed: Other studies have shown success with similar non-invasive approaches, indicating a promising avenue for treatment.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * lung cancer smaller than 5 cm * metastasis to the lung * patients with lung cancer and multiple comorbidities who are unfit for surgery Exclusion Criteria: * lung cancer larger than 5 cm * lung cancer stage II or more * patients who cannot tolerate CT guided needle placement for thermal ablation of lung tumors
Where this trial is running
Asyut
- Faculty of medicine — Asyut, Egypt (Recruiting)
Study contacts
- Principal investigator: Abdulrahman F Ali — Assiut University
- Study coordinator: Abdulrahman F Ali, Bachelor
- Email: Abdulrahman_farid@hotmail.com
- Phone: 1200742058
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.